Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study

https://doi.org/10.1016/j.diabres.2020.108263Get rights and content

Abstract

Aim

To describe the clinical characteristics and outcomes of hospitalized COVID-19 patients with diabetes.

Methods

A retrospective cross-sectional study was conducted among patients admitted to the William Harvey Hospital in England between March 10th and May10th, 2020 with a laboratory-confirmed severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), known as COVID-19. Variation in characteristics, length of stay in hospital, diabetes status, duration of diabetes, control of diabetes, comorbidities and outcomes were examined.

Results

There were 232 COVID-19 presentations. Mean (standard deviation (SD), range) age was 70.5 (±15.7, 30–101) years, 62.5% were male, and 37.5% were having diabetes. There were 43.4% males and 27.6 females, p = 0.016, with diabetes admitted to our hospital due to COVID-19. Patients with diabetes were more likely to have longer length of stay (LOS) in hospital, 14.4 (SD ± 9.6) days, compared to the patients without diabetes, 9.8 (SD ± 17.1) days, p < 0.0001. Patients with diabetic ketoacidosis (DKA) were more likely to survive (87.1%) compared to patients without DKA (50.6%), p = 0.046.

Conclusion

Males were more likely to be admitted to hospital with COVID-19 illness than females. Hospitalized COVID-19 patients with diabetes had a longer LOS in hospital than patients without diabetes. Older age COVID-19 patients with diabetes and patients without DKA were less likely to survive compared to younger patients and patients with DKA, respectively. Further studies with large sample size are needed.

Keywords

COVID-19
Diabetes
Diabetic ketoacidosis
Length of stay

Cited by (0)

1

Consultant physician diabetes and endocrinology, William Harvey Hospital, Kennington Road, Willesborough, Ashford, Kent, UK.

2

Family and Community Medicine and Behavioral Sciences department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

3

Specialist physician diabetes and endocrinology, William Harvey Hospital, Kennington Road, Willesborough, Ashford, Kent, UK.

View Abstract